Search for Clinical Trial Results
Acute Megakaryoblastic Leukemia - 188 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase Condition:
|
Completed |
Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia Condition:
|
Completed |
Study Name: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: AML Therapy With Irradiated Allogeneic Cells Condition:
|
Terminated |
Study Name: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay Condition:
|
Active, not recruiting |
Study Name: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML Condition:
|